STRIDES PHARMA SCIENCE LTD.
Market Cap.(`)
|
5884.13 Cr.
|
P/BV
|
2.59
|
Book Value (`)
|
246.48
|
52 Week High/Low ( ` )
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Book Closure
|
09/09/2024
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.39
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | -116.94 | -286.20 | -652.51 | 289.38 | 48.51 |
| | | | | |
Net CashFlow From Operating Activities | 701.07 | 44.41 | -257.82 | 481.44 | 204.79 |
Net Cash Used In Investing Activities | -150.25 | 302.47 | -118.73 | -520.82 | 1306.16 |
Net Cash Used From Financing Activities | -693.32 | -213.92 | 421.32 | -15.80 | -1709.45 |
Foreign Exchange Gains / Losses | 0.16 | 0.15 | 0.13 | -1.22 | 14.85 |
Adjustments On Amalgamation / Merger / Demerger And Others | -0.14 | -0.34 | 0.00 | 0.00 | 0.00 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | -142.48 | 132.77 | 44.90 | -56.40 | -183.66 |
Cash And Cash Equivalents Begin of Year | 303.50 | 170.73 | 125.83 | 182.23 | 365.89 |
Cash And Cash Equivalents End Of Year | 161.02 | 303.50 | 170.73 | 125.83 | 182.23 |